Fig. 2From: Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometryPI chromatograms: a (MST), b (M1), c (M2–M4), d (M5–M7), e (M8–M10) and f (MO1–MO6)Back to article page